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1. Introduction 
The first component of complement (C 1) exists 
in serum as a macromolecule with a molecular weight 
of about lo6 daltons; Cl can be dissociated by EDTA 
into three major subcomponents, Clq, Clr and Cls 
[l-3]. The Clq subcomponent has the binding site 
for complement-fixing immunoglobulins [4,5] ; the 
Clr and Cls subcomponents exist in native Cl in a 
proesterase state [6-81. It has been shown that the 
proesterase Cls is converted into ClY, the Cl esterase, 
by the purified and activated form of Clr, Cl7 [6,8]. 
Purified precursor Clr can be activated by trypsin 
[6,8]. In contrast to the activated form, Cl, Cl in 
serum has no enzymatic activity against C4 and C2, 
the natural substrates of CT; Cl as well as Cl is taken 
up by antigenantibody complexes in a time and 
temperature independent reaction [9]. The conversion 
of precursor Cl to C’l is a relatively slow, temperature 
dependent process [9,10]. 
Recently we presented evidence for an activation 
step in the Cl molecule that occurs after the binding 
of Cl and before the appearance of Cl activity; some 
data suggested that this internal activation step involves 
the subcomponents Clq [lo]. Furthermore we could 
demonstrate that in diluted serum there exist two 
different forms of Cl; both are taken up by antigen- 
antibody complexes, but only one Cl population was 
activable by itself and by trypsin; the other Cl 
population was activable by trypsin but not by itself 
indicating that in this Cl population (Cl - X) a factor 
*The nomenclature follows the recommendation of the World 
Health Organization Committee on Complement Nomen- 
clature; Immunochemistry, (1970) 7, 137-142. 
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(‘X’) is missing which is necessary for internal activa- 
tion [ 111. Since we could demonstrate that factor 
‘X’ was bound independently from Cl and (Cl - X) 
we concluded that (Cl - X) is a molecule from which 
a subunit of C 1 q is missing. 
In this report we present evidence for dissociation 
of native Cl in serum upon dilution as shown by 
ultracentrifugation. The macromolecule Cl dissociates 
into the subcomponents Clq, Clr and Cls. While the 
hemolytic activity Clr and Cls was detectable in the 
7 S and 4 S regions, respectively, no hemolytic Clq 
activity was found, not even in the 11 S part. The 
detection of Clq protein in the 7 S and about 2 S 
fractions suggests that fragmentation of Clq upon 
dilution may take place. 
2. Experimental 
The methods for the preparation of sheep 
erythrocytes (E) are given in [ 121. Partially purified 
1gG (7s) antibodies against sheep red cells were 
purchased from Cordis Corporation, Miami, Florida. 
Fresh normal human serum was kindly supplied by 
DRK Blutspendedienst Bad Kreuznach, FRG. Human 
Clq was purified from the euglobulin fraction by 
chromatography on DEAE- and CM-cellose and on 
hydroxylapatite similar to [ 13,141; the preparation 
and the criteria of the antiserum against human Clq 
are given in [ 131 . Human Cl r was purified by chromato- 
graphy on DEAE-, CM- and TEAE-cellulose and by 
polyacrylamide gel electrophoresis imilar to [ 151; 
human ClS was purified by chromatography on DEAE- 
and TEAE-cellulose and by polyacrylamide gel electro- 
phoresis similar to [7] . Partially purified guinea pig C4 
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and C2 was purchased from Cordis Corporation, Miami, 
Florida. C-EDTA as the source of late-acting com- 
ponents was prepared as described [ 121 . 
The hemolytic activity of Cl and the subcom- 
ponents of Cl were assayed using erythrocytes 
sensitized with 1gG antibodies against E (ElgG); ElgG 
were incubated with Cl or dilutions of the subcom- 
ponents to be titrated mixed with an excess of the 
other two subcomponents for 10 min at 30°C; 
afterwards the cells were washed twice and the number 
of Cl sites was determined by successive addition of 
C4 (10 min 30°C) C2 (10 min 30°C) and C-EDTA 
(60 min 37°C); the results were expressed as Z-values 
[ 121. All titrations were performed using Veronal- 
buffered sucrose saline (VBS-S: p = 0.065, pH 7.3) 
containing 0.001 M Mg” and 0.00015 M Ca2+ and 
O.l%gelatine [12]. 
The ultracentrifugation experiments were performed 
in a Spinco L265B ultracentrifuge with a Ti14 or a 
SW 40 rotor. Linear sucrose density gradients (5 to 30%) 
were prepared with Veronal-buffered saline (VBS) 
containing 0.001 M Mg”and 0.00015 M Ca2+. After 
the samples had been centrifuged at 4°C for 16 h at 
39 000 rev/min fractions were collected. 19 S (1gM) 
hemolysin and 7 S (1gG) hemolysin as markers were 
purchased from Cordis Corporation, Miami, Florida, 
and tested as described in [ 121. The immundiffusion 
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was carried out in 1% Agarose in Verona1 buffer 
pH 8.6 containing 0.005 M EDTA. 
3. Results 
3.1. Effect of dilution on native Cl 
Previous experiments concerning the activation of 
native Cl led to the conclusion that dilution of serum 
leads to a dissociation of Cl resulting in Cl molecules 
which are not able of internal activation [ 111. There- 
fore the effect of dilution on Cl in serum was 
examined in ultracentrifugation studies whereby a 
separation of the dissociation products may be possible 
The experiments were performed on a 11 ml sucrose 
density gradient from 5% to 30% sucrose dissolved in 
VBS (p = 0.06) containing 1 mM Mg”and 0.15 mM 
Ca2+. 
One gradient was overlayered with 0.2 ml of 
undiluted human serum and an other gradient with 
0.4 ml of a diluted (1: 100 in the 5% sucrose buffer) 
human serum and centrifuged with a SW 40 rotor at 
39 000 rev/min for 16 h at 4°C. In a separate gradient 
19 S and 7 S hemolysins were used as markers. After 
this time the gradients were fractionated (5 drops per 
fraction) and tested for hemolytic Cl activity. The 
results shown in fig. 1 A indicate that Cl in undiluted 
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Fig.1 (A) Cl activity after ultracentrifugation (SW 40 rotor) of undiluted and diluted (1:lOO) normal human serum on a linear 
5% to 30% sucrose gradient; 1 mM Mg’+; 0.15 mM Ca’+; n = 0.06, 16 h, 39 000 rev/min at 4°C; 19 S (IgM) and 7 S (IgG) 
hemolysins were used as markers in a separate run. (*- - - - -0) Undiluted serum; (o -0) diluted (1 :lOO) serum. (B) The 
hemolytic activity of Clq, Clr and Cls after ultracentrifugation of diluted (1:lOO) normal human serum on 5% to 30% sucrose 
gradient. (L--- n ) Clq; (o- 0) Clr; (A---- A) Cls. 
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serum appeared in the 19 S region after centrifugation. 
However, dilution of serum lead to a complete loss of 
hemolytic Cl activity. When the same fractions were 
tested for Clq, Clr.and Cls, as shown in fig.lB, Clr 
activity was found in the 7 S region and Cl s in the 4 S 
region; Clq, however, could not be detected by 
functional assays. The results of this experiment 
indicate that dilution of serum leads to a dissociation 
of the 19 S Cl molecule into its subcomponents Clr 
and Cls. Since Clq was not detectable hemolytically 
it was looked for with immunochemical methods. 
3.2. Effect of dilution on native Clq 
The following experiment were performed similar 
to those described above but a Ti14 zonal rotor was 
used. 30 ml of a 1: 100 dilution of normal human 
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serum were overlayered on a 5% to 30% sucrose 
gradient and centrifuged at 39 000 rev/min for 
16 h at 4?‘C. After centrifugation the gradient was 
fractionated (150 drops per fraction) and analysed 
for Cl, Clq, Clr and Cls activity. In a control 
experiment 30 ml of purified Clq (46 1.18 protein per 
ml) was centrifuged under the same conditions and 
the fractions were tested for hemolytic Clq activity. 
The results shown in fig.2A are in accordanck with 
the first experiment; in contrast to Clr and Cls there 
were no hemolytic activities of Cl and Clq detectable. 
However, after centrifugation of the purified Cl q 
preparation Clq activity was found in the 11s 
fractions. To be able to detect Clq protein every two 
fractions of the gradient of diluted serum were pooled, 
dialysed, concentrated and analysed in a immuno- 
diffusion test for Clq protein with rabbit anti human 
Clq antiserum. Fig.2B shows that the Clq protein was 
detectable in several different fractions of the 
centrifuged serum dilutions. The major part of the 
Clq protein was found in the 7s region (fractions 
7/8,9/ 10 and 1 l/l 2); two precipitation lines were 
seen in the 11s fractions (fractions 13/ 14 and 1 S/16) 
which correspond to the described sedimentation 
constant of purified Clq [4]. A faint precipitation line 
was found in the 19s region (fractions 31/32); Clq 
protein was also found in the first two fractions of the 
gradient (fraction l/2). These findings indicate that 
Cl q in serum dissociates into small fragments upon 
Fig.Zb 
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Fig.2. (A) Zonal ultracentrifugation of diluted (1: 100) normal human serum. Ti14 rotor; fi = 0.06; 5% to 30% sucrose gradient 
containing 1 mM MgZ’ and 0.15 mM Ca’+. 39 000 rev/min for 16 h at 4°C. Arrow indicates direction of sedimentation. (o-0) 
Cl and Clq activity; (a- A) Cl activity; (n- 0) Clr activity; (o- o) refractive index. The indicated position of 
sedimentation of purified human Clq was tested in a separate run. (B) Immunodiffusion analysis of the different, concentrated 
fractions of the sucrose gradient of flg.ZA for Clq protein with rabbit anti-human Clq. 
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Fig.3. Cl activity after ultracentrifugation (SW 40 rotor) of 
diluted (1:SO) serum to which purified Clq was added. 5% to 
30% sucrose gradient containing 1 mM Mg” and 0.15 mM 
Ca2+; p = 0.06; 39 000 rev/min for 16 h at 4°C. 
dilution. Although Clq protein was, detected 
immunochemically in the 19 S and 11 S position; Cl 
and Clq could not be detected hemolytically, this has 
to be further examined. 
3.3. Recombination of Cl in diluted serum with 
purified Cl q 
In a series of experiments the effect of purified 
Clq in diluted normal human serum was studied. 
Equal volumes of purified Clq (46 pg/ml) and of 
human serum diluted 1:50 in VBS (P = 0.06) 
containing 5% sucrose, 1 mM Mg” and 0.15 mM 
Ca2+ were mixed and incubated for 30 min at 30°C; 
samples of this mixture and of untreated serum were 
centrifuged in the descirbed manner using a SW40 
rotor. The fractionated gradients were analysed for 
Cl activity by addition of ElgG cells for 10 min at 
3O’C. Then the cells were washed three times and 
tested for Cl activity by successive addition of C4, 
C2 and C-EDTA. Fig.3 shows that addition of purified 
Clq to diluted serum leads to an appearance of Cl 
hemolytic activity in the 12.5 S region (this is a mean 
value of six different experiments). 
4. Discussion 
Thompson and Hoffman reported that the dose 
response curve serum Cl is non-linear in contrast to 
that of activated Cl (Cl) [16]. These authors could 
demonstrate that the non-linearity is not due to the 
effect of the Ci inactivator which is present in 
normal serum [ 171; they postulated a dissociation of 
serum Cl into the subcomponents Clq, Clr and Cls 
through dilution [ 171. In previous experimens [ 111 
we treated EACI 4 cells (prepared with different con- 
centrations of serum Cl) with trypsin and sub- 
sequently observed a linear dose response curve. From 
this and a series of other experiments we concluded 
that a factor necessary for internal activation of Cl is 
missing from a portion of the Cl molecules. The 
activating factor missing from Cl was found to be 
bound independently from the rest of the Cl mole- 
cule and was therefore postulated to be a portion of 
Clq; this conclusion assumes that Clq is dissociable 
[l l] . The experimental evidence for this interpre- 
tation is presented in this report by the ultracentrifu- 
gation studies which show that the native Clq sub- 
component is dissociated into fragments by dilution. 
This finding is in good accordance with the studies 
on the effect of ionic strength on Cl by Colten et al. 
[18] which allowed the assumption that Cl is com- 
posed of more than the three known subcomponents. 
Furthermore our experiments are also compatible 
with the observation that purified Clq itself is com- 
posed of nine non-covalently bound subunits, each 
subunit being a disulphide-linked dimer of two poly- 
peptide chains [ 19-221. 
In contrast to native Clq purified Clq was found 
in the 11 S portion after ultracentrifugation as 
described in the literature [4]. Therefore it seems to 
be reasonable that the inter-subunit bonds are stronger 
in the purified form than in the native Clq as it is 
present in serum. This assumption is supported by the 
recombination experiment (fig.2) with purified Clq 
in serum which resulted in a 12.5 S hemolytically active 
Cl molecule. A sedimentation constant of 12 S was 
also found for the recombined homologous human, 
guinea pig and hybrid Cl molecules made with purified 
subcomponents [3 3 . 
The major points of this report can be summarized 
as follows: First, native Cl is, in contrast to activated 
Cl (CT), a very labile molecule which can be dis- 
sociated into its subcomponents by dilution. Second, 
the most sensitive part of the native Cl molecule is 
Clq which, in contrast to purified Clq, may be partially 
dissociated into its subunits or fragments leading to a 
loss of hemolytic Clq activity. 
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